Jade Biosciences, Inc.
SEC CIK 1798749 · JBIO · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Eisner Mark | Director | filed 2026 - 2026 |
| Dobmeier Eric | Director | filed 2025 - 2026 |
| Harwin Peter Evan | Director | filed 2025 - 2026 |
| Lavelle Erin | Director | filed 2025 - 2026 |
| Klein Lawrence Otto | Director | filed 2025 - 2026 |
| Fairmount Healthcare Fund II L.P. | Director | filed 2025 - 2026 |
| Fairmount Funds Management LLC | Director | filed 2025 - 2026 |
| Cain Christopher W. | Director | filed 2025 - 2026 |
| Kiselak Tomas | Director | filed 2025 - 2026 |
| Fairmount Healthcare Co-Invest IV L.P. | Director | filed 2025 - 2026 |
| Frohlich Tom | Director · Chief Executive Officer | filed 2025 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2021 - 2025 |
| RA Capital Management, LLC | Director | filed 2021 - 2025 |
| Kolchinsky Peter | Director | filed 2021 - 2025 |
| Shah Rajeev M. | Director | filed 2021 - 2025 |
| RA Capital Nexus Fund, L.P. | Director | filed 2021 - 2024 |
| Santel Donald J | Director | filed 2023 - 2024 |
| Iwicki Mark T | Director | filed 2021 - 2024 |
| Dorval Allison | Director | filed 2021 - 2024 |
| Dable Habib J | Director | filed 2023 - 2024 |
| Resnick Joshua | Director | filed 2021 - 2024 |
| Katabi Maha | Director | filed 2021 - 2024 |
| Grayzel David S. | Director | filed 2021 - 2024 |
| Noyes Timothy P | Director · Chief Executive Officer | filed 2021 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Dahms Bradford D. | Chief Financial Officer | filed 2025 - 2026 |
| King Andrew James | See Remarks | filed 2025 - 2026 |
| Bekiroglu Elizabeth | See Remarks | filed 2025 - 2026 |
| Quick Jonathan | See Remarks | filed 2025 - 2025 |
| Kocinsky Hetal | Chief Medical Officer | filed 2025 - 2025 |
| Dake Benjamin T | See Remarks | filed 2021 - 2024 |
| Eldridge George A | See Remarks | filed 2021 - 2024 |
| Gillies Hunter | Chief Medical Officer | filed 2021 - 2024 |
| Verwijs Marinus | Senior Vice President, CMC | filed 2022 - 2024 |
| Niven Ralph | Chief Scientific Officer | filed 2021 - 2024 |
| Pigot Timothy | Chief Commercial Officer | filed 2023 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.